Interesting perspective
Hi
I had mentioned this company to a friend, whose husband is a type A kind of research person and it was interesting hear his perspective.
His concerns were as follows:
- penny stock price that his highly volatile in price.
- a glass door employee rating from 2017 that mentioned a dysfunctional workplace where the husband and wife owners have loud disagreements all the time. And who micromanage everything without realizing that they don't know everything.
- rapid CEO changeover (2 in the past 6 months alone)
- analyst ratings as a "speculative" play
He said it seems like a terrible idea to invest.
I found it fascinating as I completely agree. Everything I've read sounds like the leadership issues are big. It is speculative to a degree. The CEO changeover issues don't inspire faith at all.
I guess my only personal faith is that no matter how badly run the company is, if they are recruiting patients via the supporting centres, giving them the drug at a good dose and procedure at a good dose, that is what counts. Thankfully we are not relying on RDW's word regarding the medical results as those are controlled by the academic urologists rather than the corporate leadership. I have faith in some of the names on the med adv board and have faith in Vera and her background.
But overall, I can totally see why so many people will stay away a bit longer. Need the BTD to breakout I think.
Just in interesing perspective from my friend's husband. Thought I would share.
DJ